Pharmacokinetics: absorption, distribution, clearance
What the body does to a drug: bioavailability, volume of distribution, clearance, half-life, loading and maintenance doses, and the first-order and zero-order kinetics behind them.
By the end of this page you should be able to
- Define bioavailability and explain the factors that affect absorption by each route.
- Define volume of distribution and clearance, and relate them to half-life.
- Interpret a log concentration-time curve after an IV bolus and identify the distribution and elimination phases.
- Calculate a loading dose and a maintenance dose, and predict the time to steady state.
- Distinguish first-order and zero-order kinetics, with clinical examples.
Absorption and bioavailability
Bioavailability (F) is the fraction of an administered dose that reaches the systemic circulation unchanged. It is 1 for IV drugs by definition and is measured as the oral AUC ÷ IV AUC (dose-corrected).
Most drugs cross membranes by passive diffusion of the un-ionised, lipid-soluble form. Weak acids are less ionised in acid; weak bases less ionised in alkali (Henderson-Hasselbalch). In practice the small intestine absorbs most drugs, acid or base, because of its huge surface area and blood flow.
- First-pass metabolism: drug absorbed from the gut goes via the portal vein through the liver (and gut wall enzymes such as CYP3A4) before reaching the systemic circulation. High first-pass drugs: morphine, GTN, propranolol, lignocaine, midazolam. Sublingual, buccal, rectal (partly), transdermal, intranasal and parenteral routes avoid it.
- Formulation and gut factors: dissolution, gastric emptying (delayed by opioids, anticholinergics, shock), food, gut motility, efflux pumps (P-glycoprotein).
- IM and subcutaneous absorption depends on local blood flow: poor in shock and cold peripheries, which is why IM adrenaline in anaphylaxis goes into the vascular thigh muscle.
- Inhaled drugs act locally with little systemic effect; much of a nebulised dose is swallowed.
Distribution and volume of distribution
Volume of distribution (Vd) is the apparent volume into which a drug would have to dissolve to give the observed plasma concentration: Vd = amount in body ÷ plasma concentration. It is not a real anatomical space. Drugs that bind tissue heavily (amiodarone, tricyclics, digoxin, chloroquine) have a Vd far larger than total body water; drugs confined to plasma or ECF (heparin, gentamicin, warfarin) have a small one.
What drives Vd: lipid solubility, ionisation, plasma protein binding (keeps drug in plasma, lowers Vd) and tissue binding (raises Vd). Albumin binds acidic drugs (warfarin, phenytoin, salicylate); alpha-1 acid glycoprotein binds basic drugs (lignocaine, propranolol) and rises after surgery and trauma.
Two clinical uses: Vd decides the loading dose, and a small Vd (under about 1 L/kg) is one of the conditions for a drug to be removed usefully by haemodialysis (with low protein binding and low molecular weight: lithium, salicylate, toxic alcohols, metformin, valproate at high levels).
Clearance and half-life
Clearance (CL) is the volume of plasma completely cleared of drug per unit time: rate of elimination = CL × plasma concentration. Total clearance is the sum of hepatic, renal and other clearances.
Hepatic clearance = hepatic blood flow × extraction ratio. High extraction drugs (above 0.7: lignocaine, propranolol, morphine, GTN) are flow-limited: clearance falls when hepatic blood flow falls (shock, heart failure, beta blockers). Low extraction drugs (below 0.3: warfarin, phenytoin, theophylline, diazepam) are capacity-limited: clearance depends on enzyme activity and free fraction, so enzyme induction, inhibition and protein binding changes matter.
Half-life depends on both: t½ = 0.693 × Vd ÷ CL. A drug with a big Vd has a long half-life even if cleared efficiently. Half-life tells you how long a drug takes to fall, and how long to reach steady state.
Compartments and the concentration-time curve
After an IV bolus, plasma concentration on a log scale often shows two phases. The steep early distribution (alpha) phase is drug moving from plasma into tissues; the later straight elimination (beta) phase is removal from the body. The half-life usually quoted is the elimination half-life, from the slope of the beta line (k = 0.693 ÷ t½).
For drugs like propofol and fentanyl, the end of a single dose's effect comes from redistribution, not elimination. With a long infusion, peripheral tissues fill up, and offset slows: the context-sensitive half-time (time for the plasma concentration to halve after stopping an infusion of given duration) rises with infusion length.
Dosing: loading, maintenance and steady state
- Loading dose = target concentration × Vd ÷ F. Fills the volume quickly. Independent of clearance. Used for amiodarone, digoxin, phenytoin, vancomycin, aminoglycosides.
- Maintenance dose rate = target concentration × CL ÷ F. Replaces what is eliminated. Reduce it when clearance falls (renal or hepatic failure); the loading dose usually stays the same.
- Steady state is reached after about 4 to 5 half-lives of a constant dosing regimen (94% after 4, 97% after 5), whatever the dose. A loading dose gets there sooner; it does not change where steady state is.
- The same rule tells you elimination: after 4 to 5 half-lives, more than 90% of the drug has gone (first-order drugs only).
First-order and zero-order kinetics
First-order: a constant fraction is eliminated per unit time; rate is proportional to concentration; half-life is constant; log concentration falls in a straight line. Most drugs at therapeutic doses.
Zero-order (saturation) kinetics: a constant amount is eliminated per unit time, because the enzymes are saturated; half-life lengthens as concentration rises; small dose increases cause large, unpredictable rises in level. Examples: ethanol (at almost all concentrations), phenytoin (within the therapeutic range), salicylate and paracetamol in overdose, and thiopentone at high doses. Michaelis-Menten kinetics describe the transition: first-order well below Km, zero-order well above it.
Making the answer flow
- Lead with the definition and the equation, then the clinical consequence: "Vd is the amount in the body divided by plasma concentration; it determines the loading dose."
- Draw the log concentration-time curve and point to the two phases.
- Use renal failure as the test case: loading dose unchanged, maintenance dose reduced, time to steady state longer.
Where marks are lost
- Saying a loading dose depends on clearance, or a maintenance dose on Vd.
- Treating Vd as a real body compartment.
- Saying a loading dose changes the eventual steady-state concentration.
- Calling all overdoses zero-order. Many drugs stay first-order even in overdose.
Where this meets anaesthesia
- Context-sensitive half-time, not elimination half-life, predicts waking after an infusion; it is short and nearly constant for remifentanil and lengthens with time for fentanyl.
- Effect-site equilibration explains the delay between a bolus and its peak effect, which differs between drugs (fast for alfentanil and remifentanil, slower for morphine).
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Define volume of distribution. Why does amiodarone have such a large one, and what does that mean for dosing?
Show answer
- Vd = amount of drug in the body ÷ plasma concentration; an apparent volume.
- Amiodarone is highly lipid soluble and binds extensively to tissues (fat, muscle, liver, lung); Vd is many times total body water (around 60 L/kg).
- Needs a loading dose to achieve effect; very long elimination half-life (weeks to months) because t½ = 0.693 × Vd ÷ CL.
- Early IV effect depends on distribution to the heart, not total body loading.
- 2.
What is bioavailability and what factors reduce it after an oral dose?
Show answer
- Fraction of an administered dose reaching systemic circulation unchanged; AUC oral ÷ AUC IV.
- Pharmaceutical: formulation, dissolution, particle size.
- Patient: gastric emptying, gut motility, food, gut wall metabolism (CYP3A4), P-glycoprotein efflux, first-pass hepatic metabolism, gut disease.
- Drug: ionisation, lipid solubility, instability in acid (benzylpenicillin).
- Examples of high first pass: morphine (about 30%), GTN (near zero, so sublingual).
- 3.
A patient with acute kidney injury needs gentamicin. How do you adjust the dose?
Show answer
- Gentamicin: polar, small Vd (about ECF), renally excreted unchanged.
- Loading (first) dose depends on Vd and should not be reduced; underdosing in sepsis is a risk, and Vd may be raised by resuscitation fluid.
- Clearance is reduced, so extend the dosing interval (or avoid repeat doses) guided by levels.
- Toxicity (nephro and oto) relates to trough exposure; efficacy to peak (concentration-dependent killing).
- 4.
Explain the difference between first-order and zero-order kinetics with clinical examples.
Show answer
- First-order: constant fraction removed per unit time; constant half-life; exponential decline; linear on log plot.
- Zero-order: constant amount removed per unit time; enzymes saturated; half-life rises with concentration.
- Examples: ethanol (about 7 to 10 g per hour in an adult, roughly one standard drink), phenytoin within the therapeutic range, salicylate and paracetamol in overdose.
- Michaelis-Menten: rate = Vmax × C ÷ (Km + C).
- Consequence: small dose changes cause disproportionate level changes; prolonged toxicity.
- 5.
How long does it take to reach steady state, and how can you get there faster?
Show answer
- About 4 to 5 elimination half-lives regardless of dose or interval (first-order drugs).
- Loading dose achieves target concentration immediately; then maintenance dose sustains it.
- Example: digoxin (t½ about 36 hours) takes about a week without loading; amiodarone months.
- If half-life is prolonged (renal failure for digoxin), time to steady state is longer too.
- 6.
What is hepatic extraction ratio and why does it matter for a patient in shock?
Show answer
- Fraction of drug removed in one pass through the liver; hepatic clearance = Q × ER.
- High ER drugs (lignocaine, morphine, propranolol): clearance depends on hepatic blood flow, which falls in shock, heart failure and with beta blockers, so levels rise.
- Low ER drugs (warfarin, phenytoin, theophylline): clearance depends on enzyme capacity and free fraction; sensitive to induction, inhibition and protein binding.
- Example: lignocaine toxicity more likely in cardiogenic shock.
- 7.
Draw the concentration-time curve after an IV bolus of a drug that follows a two-compartment model.
Show answer
- Log concentration on y axis, time on x axis.
- Rapid initial fall (alpha, distribution phase) then a straight line (beta, elimination phase).
- Back-extrapolate the beta line to y intercept; slope gives k and the elimination half-life.
- Mention context-sensitive half-time for infused lipophilic drugs, where redistribution governs offset.
- 8.
Which properties make a drug removable by haemodialysis? Give examples from toxicology.
Show answer
- Low molecular weight, low protein binding, small Vd (under about 1 L/kg), water soluble, and a clearance by dialysis that adds meaningfully to endogenous clearance.
- Examples: lithium, salicylate, toxic alcohols and their metabolites, metformin lactic acidosis, valproate and carbamazepine at high levels, theophylline.
- Not removed usefully: tricyclics, digoxin, amiodarone, benzodiazepines, calcium channel blockers (large Vd or high protein binding).
- 9.
Why does fentanyl wear off quickly after a single dose but slowly after a long infusion?
Show answer
- Highly lipid soluble; after a bolus the effect ends by redistribution from brain and plasma into muscle and fat.
- During a long infusion peripheral compartments fill; when stopped, drug returns from them to plasma.
- Context-sensitive half-time rises with infusion duration (fentanyl markedly; remifentanil constant because of esterase metabolism).
- Elimination half-life alone does not predict offset of lipophilic drugs.
Practise this week
- Physiology Bench: move the graphs yourself
- Primary MCQs: pharmacology
- Primary SAQs, marked part by part
- Primary vivas
- Viva Examiner: practise answering aloud
Week 2 in the other subjects
- Physiology: Membrane potentials and the action potential
Not affiliated with the Australian and New Zealand College of Anaesthetists (ANZCA). Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.